Yoshida Kazushige, Tensho Keiji, Maezumi Yusuke, Kumaki Daiki, Shimodaira Hiroki, Horiuchi Hiroshi, Takahashi Jun
Department of Orthopedic Surgery, Shinshu University School of Medicine, Nagano, Japan.
Department of Rehabilitation, Shinshu University Hospital, Nagano, Japan.
Arthrosc Tech. 2024 May 27;13(9):103042. doi: 10.1016/j.eats.2024.103042. eCollection 2024 Sep.
The menisci have a poor intrinsic healing capability. Biological augmentation is used to promote meniscal healing in conjunction with suture techniques as the result of their poor healing rate. A fibrin clot (FC) is a well-known treatment option for meniscal injuries that are difficult to heal. Several methods for delivering FCs to target sites have been reported; however, all available methods have drawbacks such as unstable delivery, low maneuverability, and/or clot sizes that are too large. We use a dedicated device to efficiently deliver FCs of a suitable size for the tear. In this method, an FC formed to a size of 5 mm is stored and delivered in a thin syringe with a built-in plunger. This method enables an accurate delivery of a suitably sized FC to the desired location and fixes FCs to the tear site when used in combination with conventional suture methods. In this report, we will succinctly describe how to make and deliver an FC using the aforementioned device with a step-by-step instructional technique and an illustrative video.
半月板自身愈合能力较差。由于其愈合率低,生物增强技术与缝合技术联合使用以促进半月板愈合。纤维蛋白凝块(FC)是治疗难以愈合的半月板损伤的一种众所周知的方法。已经报道了几种将FC输送到目标部位的方法;然而,所有现有方法都存在缺点,如输送不稳定、可操作性低和/或凝块尺寸过大。我们使用一种专用装置来有效地输送适合撕裂大小的FC。在这种方法中,形成5毫米大小的FC被存储在带有内置柱塞的细注射器中并进行输送。这种方法能够将合适大小的FC准确地输送到所需位置,并且当与传统缝合方法结合使用时可将FC固定在撕裂部位。在本报告中,我们将通过分步指导技术和演示视频简要描述如何使用上述装置制作和输送FC。